Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | MMP9 | P14780 | 1/20 | 0.32 |
| ▸ | MMP12 | P39900 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 3/20 | 0.32 |
| ▸ | CA1 | P00915 | 3/20 | 0.32 |
| ▸ | CA2 | P00918 | 3/20 | 0.32 |
| ▸ | CA9 | Q16790 | 3/20 | 0.32 |
| ▸ | CD69 | Q07108 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24140922 | 0.89 | LMNA (0.44) | LMNAKMT2AALDH1A1POLBCYP3A4 | |
| SCHEMBL913345 | 0.85 | LMNA (0.56) | LMNAKMT2AALDH1A1POLBCYP3A4 | |
| SCHEMBL913346 | 0.85 | LMNA (0.56) | LMNAKMT2AALDH1A1POLBCYP3A4 | |
| SCHEMBL8023508 | 0.80 | LMNA (0.45) | LMNAKMT2AALDH1A1POLBCYP3A4 | |
| SCHEMBL8023515 | 0.80 | LMNA (0.45) | LMNAKMT2AALDH1A1POLBCYP3A4 | |
| SCHEMBL912857 | 0.77 | LMNA (0.56) | LMNAKMT2AALDH1A1POLBCYP3A4 | |
| SCHEMBL29586206 | 0.77 | LMNA (0.56) | LMNAKMT2AALDH1A1POLBCYP3A4 | |
| SCHEMBL912858 | 0.77 | LMNA (0.56) | LMNAKMT2AALDH1A1POLBCYP3A4 | |
| SCHEMBL7801083 | 0.76 | CYP2D6 (0.48) | LMNAMAPTTHRBCYP2D6HSD17B10 | |
| SCHEMBL19837860 | 0.76 | CYP2D6 (0.48) | LMNAMAPTTHRBCYP2D6HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210402002-A1 | CONJUGATE | GLYKOS BIOMEDICAL OY (FI) | 2021-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210402002-A1 | CONJUGATE | ST6GAL1, CSGALNACT1, FUT6 | LMNA 4446/4885KMT2A 2980/4885ALDH1A1 1428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.